APPLIED DNA SCIENCES INCAPDN

時価総額

PER

	2011年 9月30日	2019年 9月30日	2020年 9月30日	2021年 9月30日	2022年 9月30日
Cash and cash equivalents	3	558,988	8	7	15
Accounts Receivable, Net, Current, Total	208,587	839,951	194,319	3	3
Inventories	-	142,629	497,367	1	602,244
Prepaid expenses and other current assets	-	604,740	599,296	568,881	1
Total current assets	3	2	9	11	20
Property and equipment, net	89,108	226,221	1	3	2
Deposits	-	62,351	95,083	95,040	98,997
Total assets	4	4	11	14	22
Accounts payable and accrued liabilities	768,061	2	2	3	4
Deferred revenue	-	628,993	511,036	281,000	563,557
Total current liabilities	4	2	4	3	4
Long term accrued liabilities	-	621,970	848,307	31,467	31,467
Common Warrant liability	-	-	-	-	5
Total liabilities	-	4	6	3	9
Common Stock, Value, Issued	473,326	1,200	5,144	7,488	12,909
Additional paid in capital	160	256	276	295	305
Accumulated deficit	-161,856,427	-256,805,589	-269,835,650	-284,122,092	-292,500,088
Applied DNA Sciences, Inc. stockholders' equity:	-995,385	-841,459	6	11	13
Noncontrolling interest	-	-7,040	-8,725	-722	-2,890
Total equity	-	-848,499	6	11	13
Total liabilities and equity	4	4	11	14	22